Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Medibank Private ( (AU:MPL) ) just unveiled an announcement.
Medibank Private Limited announced the cessation of 1,025,688 performance rights due to the lapse of conditional rights, as the conditions were not met or became incapable of being satisfied. This announcement may impact the company’s capital structure and could have implications for stakeholders, reflecting on the company’s operational adjustments and strategic focus.
The most recent analyst rating on (AU:MPL) stock is a Hold with a A$5.05 price target. To see the full list of analyst forecasts on Medibank Private stock, see the AU:MPL Stock Forecast page.
More about Medibank Private
Medibank Private Limited operates in the health insurance industry, offering a range of health insurance products and services to individuals and businesses in Australia. The company focuses on providing comprehensive health coverage and related services to enhance the well-being of its customers.
Average Trading Volume: 5,381,255
Technical Sentiment Signal: Buy
Current Market Cap: A$13.74B
See more data about MPL stock on TipRanks’ Stock Analysis page.